Refine Results
Formats
  1. Journal Article (59409)
  2. Meeting Abstract (27341)
  3. Book Section (4247)
  4. Review (1824)
  5. Conference Paper (1349)
  6. Editorial (1101)
  7. Correspondence (368)
  8. Guidelines (363)
  9. Book Whole (301)
  10. Research Letter (261)
  11. Miscellaneous (158)
Groups
  1. Department of Medicine (31339)
  2. GSK Faculty (18279)
  3. Solid Tumor Oncology Division (17670)
  4. Surgery (17582)
  5. Sloan Kettering Institute Faculty (15960)
  6. Survivorship Research (13035)

More Groups

People
  1. Marc Ladanyi (1179)
  2. Victor Reuter (1158)
  3. Robert Motzer (1076)
  4. Howard Scher (1071)
  5. Murray Brennan (1022)
  6. David Klimstra (959)

More People

Years
  1. 2022 (1928)
  2. 2021 (5378)
  3. 2020 (5342)
  4. 2019 (5526)
  5. 2018 (5198)
  6. 2017 (4900)

More Years

Publications
  1. Journal of Clinical Oncology (6966)
  2. Blood (3661)
  3. Cancer Research (2485)
  4. International Journal of Radiation Oncology, Biology, Physics (2181)
  5. Modern Pathology (1746)
  6. Laboratory Investigation (1604)

More Publications

Publishers
  1. Elsevier Inc. (11363)
  2. American Society of Clinical Oncology (7358)
  3. Springer (5934)
  4. American Association for Cancer Research (5390)
  5. Nature Publishing Group (5215)
  6. Elsevier Science, Inc. (4736)

More Publishers

Results (96722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of neoadjuvant androgen deprivation therapy (NADT) on erectile function recovery (EFR) after radical prostatectomy (RP)
    Meeting Abstract

    Flores Martinez, J.; Jenkins, L. C.; Benfante, N.; Touijer, K.; Mulhall, J. P.
    Journal of Sexual Medicine (2022)

    Fulltext@MSK | Save
  • Checkpoint inhibition induced pruritus during cancer therapy is associated with skin IL-31 and CCL22 expression
    Meeting Abstract

    Wang, E.; Lyubchenko, T.; Goleva, E.; Kraehenbuehl, L.; Ketosugbo, K.; Moy, A.; Hellmann, M.; Kern, J.; Lacouture, M.; Leung, D.
    Journal of Allergy and Clinical Immunology (2022)

    Fulltext@MSK | Save
  • SREBP2 restricts osteoclast differentiation and activity by regulating IRF7 and limits inflammatory bone erosion
    Meeting Abstract

    Kim, H.; Bae, S.; Kaneko, K.; Giannopoulou, E.; Deng, L.; Park-Min, K. H.
    Journal of Bone and Mineral Research (2022)

    Fulltext@MSK | Save
  • Myeloid lineage ablation of Phlpp1 regulates M-CSF signaling and tempers bone resorption in female mice
    Meeting Abstract

    Karkache, I.; Damodaran, J.; Molstad, D.; Bradley, E.; Mansky, K.
    Journal of Bone and Mineral Research (2022)

    Fulltext@MSK | Save
  • Antinuclear antibodies in myelodysplastic syndrome: A retrospective study
    Meeting Abstract

    Cristiano, A.; Nuccetelli, M.; Hajrullaj, H.; Falconi, G.; Galossi, E.; Fenu, S.; Latagliata, R.; Tafuri, A.; Sarlo, C.; Palmieri, R.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Genetic variants associated with childhood cancers: Curation initiatives of the ClinGen Somatic Cancer Pediatric Taskforce
    Meeting Abstract

    Williams, H.; Krysiak, K.; Lin, W. H.; Roy, A.; Church, A.; Saliba, J.; Rao, S.; Ritter, D.; Danos, A.; Corson, L.; more...
    Genetics in Medicine (2022)

    Fulltext@MSK | Save
  • The Clinical Genome Resource (ClinGen) Somatic Cancer Clinical Domain Working Group
    Meeting Abstract

    Saliba, J.; Raca, G.; Roy, A.; King, I.; Selvarajah, S.; Xu, X.; Kanagal-Shamana, R.; Satgunaseelan, L.; Meredith, D.; Evans, M.; more...
    Genetics in Medicine (2022)

    Fulltext@MSK | Save
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated mantle cell lymphoma: Updated results from the phase 1/2 BRUIN study
    Meeting Abstract

    Wang, M.; Shah, N.; Alencar, A.; Gerson, J.; Patel, M.; Fakhri, B.; Jurczak, W.; Tan, X.; Lewis, K.; Fenske, T.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial
    Meeting Abstract

    Musiek, A.; Whittaker, S.; Horwitz, S.; Bagot, M.; Huen, A.; Fisher, D.; Haun, P.; Vermeer, M.; Ito, T.; Dwyer, K.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Exploratory analysis: Potential of pelabresib (CPI-0610), a bromodomain and extra-terminal domain inhibitor, as suggested by analysis of improvements in bone marrow histology and function in patients with myelofibrosis-preliminary data
    Meeting Abstract

    Harrison, C.; Verstovsek, S.; Salama, M. E.; Mascarenhas, J.; Talpaz, M.; Mesa, R.; Vannucchi, A. M.; Rampal, R. K.; Oh, S.; Olteanu, H.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save